Last line of defence! How 7 Nifty stocks survived the market’s two-month bloodbath
Kotak Mahindra Bank moved lower in a defence development.
· ET Stocks, Economic Times Markets
In an unprecedented downturn, the Nifty has faced its longest losing streak in 25 years, sliding for over eight weeks as foreign investors withdrew significant funds from Indian equities. Despite this market decline in September, seven stocks, led by Kotak Mahindra Bank and Dr Reddy's Laboratories, demonstrated resilience.
The analysis
Against that, the stock is -1.4% on the day at ₹433.90, and has returned +18.3% over three months. It is trading close to its 52-week high, so expectations were already elevated going in. The banks sector has moved -1.7% over the same period, so Kotak Mahindra Bank is running 20.0 points ahead of its peers.
For Kotak Mahindra Bank, the question is how much of this is already reflected in the price and how much re-rates the banks peer set alongside it.
Why it matters
- Defence orders carry long execution tails and policy tailwinds, which the market values for their visibility.
Market context
- The company directly in focus is KOTAKBANK.
- Sector exposure: Banks, Pharma & Healthcare.
- The immediate tone of coverage reads negative.
In this story
Related coverage
Stock Market Highlights: Sensex, Nifty Snap 2-Day Winning Run; SMIDs Mixed; Titan Top Loser
Market wrap: Kotak Bank, Bharti Airtel, Titan Company, Adani Ent top gainers and losers on Nifty and Sensex on Wednesday
Pharma stocks to buy ahead of Q2 results: Acutaas Chemicals, Mankind Pharma, Ipca Labs - Max upside? Target price
PNB, Kotak Mahindra Bank, other bank stocks rise up to 2% after RBI’s rate hike, Nifty Bank above 55,500
Banks vs NBFCs: Which stocks could benefit as RBI set to hike rates for the first time in 3 years?